Title : Beyond the limitation of randomized controlled trials ( RCTs ) - current drug repositioning by using human induced pluripotent stem ( iPS ) cells technology

Sorry, there's nothing here.

Cite this paper

@inproceedings{Okabe2017TitleB, title={Title : Beyond the limitation of randomized controlled trials ( RCTs ) - current drug repositioning by using human induced pluripotent stem ( iPS ) cells technology}, author={Midori Okabe and Shinya Yamanaka}, year={2017} }